Trial
NCT03185871
Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
National Cancer Institute (NCI)
Condition
Breast Carcinoma
Intervention
Celecoxib
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-15